BioSpace News Archive

IQVIA™ (NYSE:IQV) today announced the launch of IQVIA MedTech and its dedicated industry focused solutions and services for the medical device and in vitro diagnostics market, and for companies with combination products.

The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announced today the release of its financial and operating results for the three and nine months ended March 31, 2019.

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group, are taking action to help people affected by flooding across parts of Mississippi.

The Centers for Disease Control and Prevention is clarifying its guidelines on opioid prescribing, citing the findings of a review panel led by Regenstrief Institute Research Scientist Kurt Kroenke, M.D. Dr. Kroenke and his colleagues found that many clinicians, policymakers and payers are misapplying the CDC’s guidelines, and those actions are negatively affecting patients.

Modus Therapeutics AB announces the initial results from its Phase II, randomized, double-blind, placebo-controlled study with sevuparin for the management of acute vaso-occlusive crisis (VOC) in patients with sickle cell disease.

The Journal of Medical Device Regulation reaches regulatory professionals around the world and provides them with in depth articles on current regulatory matters as well as topical information on international regulatory changes.

Celixir, a privately-owned company discovering and developing life-saving advanced therapies, is pleased to announce the publication of in vitro study results highlighting the potential of its novel cancer gene therapies targeting solid tumours.

BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lannett Company, Inc..

Highly multiplexed test offers workflow advantages to support the Flu season surge